Atlas Trials

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Clinical trial NCT00391196 · TERMINATED

Trial details

NCT number
NCT00391196
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Obesity
Start date
2006-11-01
Primary completion
2008-12-01
Enrollment
975

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.